NEWS
Ryman rights its wrongs and analyst increases target price

CHRISTCHURCH: An analyst historically critical of Ryman Healthcare’s financial management has boosted its ... read more
Aristocrat jackpot with S&P upgrade from junk to investment

SYDNEY: Ratings agency S&P Global has upgraded Aristocrat from junk territory to investment ... read more